Objective-Sarcopenia or low muscle mass is related to cardiovascular risk factors; however, the association between low muscle mass and subclinical atherosclerosis has been largely unexplored. We investigated whether muscle mass is related to coronary artery calcification (CAC) in a large sample of middle-aged asymptomatic adults. Approach and Results-We performed a cross-sectional study of 31 108 asymptomatic adults without cancer, diabetes mellitus, or known cardiovascular disease who underwent a health checkup examination including cardiac tomography estimation of CAC scores between 2012 and 2013. Skeletal muscle mass index (SMI) [SMI (%)=total skeletal muscle mass (kg)/body weight (kg)×100] was estimated using a bioelectrical impedance analyzer. We assessed the relationship between SMI and CAC scores using both multivariate-adjusted Tobit models and multinomial logistic regression models. Of the 31 108 subjects, 3374 subjects (10.9%) had a CAC score 1 to 100, and 628 subjects (2.0%) had a CAC score >100. SMI was inversely associated with CAC score ratios. Specifically, in a multivariable-adjusted model adjusting for potential confounders, CAC score ratios (95% confidence intervals) of SMI for quartiles 1, 2, and 3 compared with quartile 4 were 2.27 (1.70-3.05), 1.46 (1.15-1.85), and 1.24 (0.98-1.55), respectively (P for trend <0.001). Adjusting for insulin resistance reduced the magnitude of the associations, but they remained statistically significant. Conclusions-Relative muscle mass was negatively associated with the prevalence of coronary calcification, supporting low muscle mass as an independent risk factor of coronary heart disease. 
C oronary heart disease (CHD) has threatened the modern society and is the leading cause of death in the United States and in the world.
1,2 Moreover, the number of deaths by CHD has increased over the past decade from 6 million in 2000 to 7.4 million in 2012, 2 which means that more effort is needed to control the mortality and morbidity from CHD. Coronary artery calcification (CAC) scoring using computed tomography is a useful method to identify subclinical atherosclerosis. 3 CAC scores reflect the long-term impact of elevated cardiovascular disease (CVD) risk factors and independently predict future risk of CVD events. 4 Sarcopenia or low muscle mass is another emerging health issue in our aging society. Sarcopenia has been defined as the loss of skeletal muscle mass and strength with aging and is recognized as a geriatric syndrome. 5 It may accompany functional impairment and disability. 6 Low muscle mass has also been known to be associated with type 2 diabetes mellitus, metabolic syndrome, nonalcoholic fatty liver disease, and cardiovascular risk factors [7] [8] [9] [10] and may even be related to major adverse cardiovascular events and mortality. 11 Indeed, these observations have been observed not only in the elderly, but also in the general population, including young adults. 7, 8, [10] [11] [12] Insulin resistance has been proposed to underlie the relationship between low muscle mass and CVD 12 ; however, the exact mechanisms remain to be elucidated. There is scanty literature on the relationship between muscle mass and arterial stiffness or atherosclerosis, 13, 14 and to the best of our knowledge, no study has tested the association between muscle mass and CAC.
We aimed to investigate whether relative muscle mass is related to CAC in a large sample of middle-aged asymptomatic adults who participated in a health screening examination program. We further evaluated whether the putative association between relative muscle mass and CAC was independent of insulin resistance.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Baseline characteristics of study subjects according to quartiles of skeletal muscle mass index (SMI) are described in Table 1 .8), respectively. Of the 31 108 subjects, 4000 (12.9%) had class I sarcopenia and 749 subjects (2.4%) had class II sarcopenia. The prevalence of current smoker status, hypertension, obesity, class I and class II sarcopenic obesity were 27.2%, 14.8%, 37.0%, 10.0%, and 2.3%, respectively. The factors that were negatively associated with SMI were age, body mass index, blood pressure, glucose, uric acid, total cholesterol, low-density lipoprotein cholesterol, triglycerides, alanine aminotransferase, γ-glutamyltransferase, high-sensitivity C-reactive protein (CRP), homeostasis model assessment of insulin resistance (HOMA-IR), CAC score, high alcohol consumption, hypertension, and use of dyslipidemia medication. Conversely, education level, high-density lipoprotein cholesterol, and physical activity level (health-enhancing physically active) were positively associated with SMI. Of the 31 108 subjects, 3374 subjects (10.9%) had a CAC score 1 to 100 and 628 subjects (2.0%) had a CAC score >100. CAC scores increased with increasing sarcopenia class (P value <0.001). The mean CAC scores of subjects with class II sarcopenia and class I sarcopenia and those without sarcopenia were 11.8, 9.6, and 8.6, respectively. Table 2 shows the relationship between SMI quartile and CAC score ratios. SMI was inversely associated with CAC score ratios. In an age-and sex-adjusted model, CAC score ratios (95% confidence intervals) of SMI for quartiles 1, 2, and 3 compared with the highest quartile was 2.22 (1.66-2.97), 1.46 (1.16-1.84), and 1.25 (1.00-1.57), respectively (P for trend <0.001). After further adjusting for screening center, year of screening examination, smoking status, alcohol intake, To explore whether the association between SMI and the prevalence of coronary calcification was affected by insulin resistance, we performed an additional analysis adjusting for HOMA-IR. Adjusting for HOMA-IR reduced the magnitude of the associations, but they remained statistically significant (Table 2 , model 2). These results did not change after additional adjustment for high-sensitivity CRP (data not shown). Similar findings were observed in the multinomial logistic regression models with categorized CAC scores (CAC score 1-100 and >100 compared with a reference CAC score of 0; Table 3 ).
The associations between SMI and the prevalence of coronary calcification were next examined in subgroups of study participants. The interaction between SMI and age in coronary calcification was statistically significant (P for interaction 0.002). The association between SMI and the prevalence of coronary calcification was stronger in older participants (≥50 years) than in younger participants (<50 years). The association between SMI and CAC score ratios was similar across participant subgroups with no significant interactions between sex (women versus men), smoking (never or exsmoker versus current smoker), alcohol intake (<20 versus ≥20 g of alcohol per day), health-enhancing physically active (no versus yes), HOMA-IR (<2.5 versus ≥2.5), and high-sensitivity CRP levels (<1.0 mg/L versus ≥1.0 mg/L; Table 4 ).
Discussion
In this large study of a middle-aged Korean population, low relative muscle mass was associated with an increased prevalence for subclinical coronary artery disease and the degree of CAC in a dose-dependent manner. This association remained significant after adjustment for many possible confounders, including HOMA-IR, and was consistently observed in various subgroups. To the best of our knowledge, this is the first study to demonstrate the relationship between low relative *Estimated from robust Tobit regression models used with natural log(CAC+1) as the outcome. Models were adjusted for age, sex, center, year of screening examination, smoking status, alcohol intake, physical activity, educational level, total calorie intake, and family history of cardiovascular disease.
†Skeletal muscle index quartile levels. Quartile 1, 21.7%-39.6%; quartile 2, 39.7%-42.4%; quartile 3, 42.5%-44.6%; and quartile 4, 44.7%-55.4%.
muscle mass and subclinical coronary atherosclerosis, as measured by CAC score.
There have been several studies demonstrating that low urinary creatinine excretion, an indirect measure of muscle mass, was associated with major adverse cardiovascular events and all-cause mortality in prospective studies. 11, 15 Moreover, low relative muscle mass, assessed by SMI, was associated with an increased cardiovascular risk in a Korean population. 7, 16 A cross-sectional study in Japan showed that low relative muscle mass was related to greater arterial stiffness in women, 13 which supports the possibility that a common pathway may exist between low muscle mass and atherosclerosis. Insulin resistance may explain the association between them as an intermediate or a confounder and has been investigated in several studies. [10] [11] [12] Diminished insulin sensitivity could induce autophagy by inhibiting the mammalian target of rapamycin pathway and thus contributing to accelerated muscle loss. The function of insulin growth factor-1, which could stimulate protein synthesis, is also suppressed in insulin resistance and, therefore, could induce the degradation of muscle protein by the ubiquitin-proteasome pathway. The insulin-resistant condition, such as in obesity and diabetes mellitus, is associated with mitochondrial dysfunction. Indeed, long-term insulin resistance is associated with loss of muscle mass and strength. 17 Conversely, low muscle mass may increase insulin resistance because muscle is the primary site of whole-body insulin-mediated glucose disposal.
12 Physical inactivity may represent a possible connection between low muscle mass and atherosclerosis as well because low levels of physical activity can result in low muscle mass. Certainly, there is a body of literature that shows the beneficial effects of physical activity on CHD. 18, 19 Herein, we showed that after adjusting for HOMA-IR and physical activity, the association between low relative muscle mass and CAC was significant. This implies that there may be some factors that are not explainable only by insulin resistance and physical activity underlying the relationship between low relative muscle mass and CAC. High CRP level was related to a risk of losing muscle strength in a prospective study. 20 The concentration of CRP also predicted the longterm risk of a first myocardial infarction and stroke 21 and, thus, may have a role between low muscle mass and CHD. In the current study, however, the association between low relative muscle mass and CAC remained significant even after adjustment of high-sensitivity CRP. However, other inflammatory or proinflammatory markers that were not available in this study can be involved. Interleukin 6, a proinflammatory cytokine, was negatively associated with appendicular lean mass independent of fat mass. 22 A meta-analysis demonstrated a causal relationship between the interleukin 6 receptor-related pathway and CHD, 23 and therefore, interleukin 6 may act as a mediator between low muscle mass and the development of CHD. Fibroblast growth factor 21 is another myokine induced in skeletal muscle by insulin stimulation. 24 In a murine model, fibroblast growth factor 21 improved left ventricular dysfunction after myocardial infarction and increased the plasma concentration of adiponectin, possibly playing a role in the relationship between muscle mass and CHD. 25 Strengths of our study include the large sample size, the use of carefully standardized clinical, imaging, and laboratory procedures, stringent quality control for data acquisition and analysis, and the availability of potential confounding variables.
However, several limitations in this study should be considered. First, the cross-sectional design of the study precludes the determination of a causal relationship. Second, we used bioelectrical impedance analyzer to estimate the skeletal muscle mass. Bioelectrical impedance analyzer-measured muscle mass depends on the relationship between body composition and body water content, which can be inaccurate in some conditions, such as heart failure and chronic kidney disease. However, we studied asymptomatic, relatively young, mostly working people free of cancer, diabetes mellitus, and clinically manifest CVD, thereby minimizing this limitation. Moreover, skeletal muscle mass by bioelectrical impedance analyzer, a relatively simple, quick, and noninvasive method, was found to be reasonably accurate compared with dual X-ray absorptiometry in a healthy population. 26 Third, we did not assess skeletal muscle function, which may affect the relationship described herein. Fourth, information on activity levels was self-reported. This may have affected the reliability of the data and, therefore, could limit the assessment of exercise as a modifier or a confounder in the association between muscle mass and CAC score. Finally, our study was conducted in asymptomatic, relatively young Korean men and women, and our findings may not be generalizable to older populations and other populations.
In conclusion, low relative muscle mass was independently associated with a higher prevalence of coronary calcification, supporting low muscle mass itself as a risk for CHD, independent of insulin resistance or physical inactivity.
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Figure.
Flow chart of study participants. As some individuals met >1 exclusion criterion, the total number of subjects included in the study was 31 108.
The association between low muscle mass and subclinical atherosclerosis has been largely unexplored. We investigated whether muscle mass is related to coronary artery calcification in a large sample of middle-aged asymptomatic adults (N=31 108). We found that relative muscle mass was negatively associated with the prevalence of coronary calcification in a dose-dependent manner, supporting low muscle mass as a risk factor of coronary heart disease, independent of insulin resistance or physical inactivity.
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